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718a Wednesday, February 24, 2010Drosophila melanogaster possess a simple linear heart tube and constitute an
excellent genetic model system with which to investigate the effects of cardi-
omyopathic mutation. The Mhc5 myosin heavy chain mutation is located in the
‘transducer’domain and elicits hypercontractile function at the molecular level
characterized by high ATPase activity and enhanced in vitro motility proper-
ties. Additionally, its expression impairs diastolic relaxation of the cardiac
tube reminiscent of restrictive cardiomyopathy in humans. We have investi-
gated the effect of the Mhc5 mutation on cardiac structure/function by quanti-
tative proteomics using isobaric tags for relative quantification (iTRAQ). Ex-
cised fly hearts from yw (control) and Mhc5 strains were digested with
trypsin, reduced, alkylated and labeled with ITRAQ reagent. Peptides from
each pool were mixed together prior to fractionation by strong cation exchange
chromatography and subsequent reversed-phase HPLC coupled to tandem mass
spectrometry. This approach identified approximately 600 proteins, of which
94 were upregulated and 86 were downregulated in Mhc5 hearts relative to
yw hearts (p<0.05). Ontological cluster analysis of the genes encoding the reg-
ulated proteins revealed that myofibrillar disarray in Mhc5 hearts likely stems
from overexpression of actin with concomitant reduction of myofibrillar assem-
bly proteins such as spectrin, and other actin-binding proteins. Structural re-
modeling was also characterized by increased expression of extracellular ma-
trix proteins. Upregulation of proteins involved in mitochondrial oxidative
phosphorylation and fatty acid catabolism suggests further bioenergetic remod-
eling. The proteomic, structural and ultrastructural data are consistent with
a model whereby the elevated ATPase activity caused by Mhc5 mutation in-
creases energetic demand, thereby stimulating a concerted compensatory met-
abolic response to maintain energetic homeostasis. Ongoing protein-network/
interactome analysis will help to further refine the model.
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Possible therapeutic benefits of stem cell treatments have been widely investi-
gated recently. We have presented initial reports that co-culturing mesenchy-
mal stem cells (MSC, Lonza) with rat heart cells in primary culture can prevent
the consequences of the treatment with a inflammatory bacterial endotoxin
(LPS, Lipopolysaccharide-A). We now investigate how the MSC produce their
beneficial actions. Using sparse primary cultures of neonatal rat ventricular or
adult rat ventricular myocytes with either MSC or control cells (fibroblasts), we
examine cardiac Ca2þ signaling. LPS causes Ca2þ signaling anomalies which
include delayed afterdepolarizations (DADs) and Ca2þ-enhanced early afterde-
polarizations (EADs). We find that co-cultures with cells co-mingled can pre-
vent the untowards actions of LPS on the cardiac myocytes. The negative con-
sequences of LPS are alterations in the normal [Ca2þ]i transient that is
stimulated by field shocks as described above. Since the benefit of MSC co-cul-
ture are found even when a solute per-
meable / cell impermeant membrane
separates the MSC from the LPS
treated cardiac myocytes, we con-
clude that a paracrine action of the
MSC can account for the treatment at-
tributed to the MSCs. We continue to
investigate possible beneficial signal-
ing pathways that may explain the
paracrine effect of MSCs.3734-Pos
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Cell-based cardiac repair following myocardial infarction has gained consider-
able interest recently, and the human pluripotent stem cell is an attractive cell
source due its efficient differentiation into immature but functional cardiomyo-
cytes. We examined the biophysical characteristics of cardiomyocytes gener-
ated from human embryonic stem cells (hESC-CMs) by measuring calcium
transients, single cell contractions, and actomyosin interactions via flash pho-
tolysis. Furthermore, we compared these characteristics with those obtained
from a second promising but still poorly characterized cell type, the human in-duced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM). We hypothe-
sized that understanding fundamental biochemical and mechanical characteris-
tics of these cells would provide insight into potential strategies to induce
further cell maturation in vitro.
Our results suggest that hESC-CMs and hiPSC-CMs exhibit spontaneous con-
tractions and calcium transients with similar kinetics, including time to peak
[Ca2þ]i (116534ms vs. 155540ms) and time to 50% [Ca
2þ]i decay
(352587ms vs. 296549ms). Furthermore, quantitative videomicroscopy of
resulting single cell contractions suggests that cardiomyocytes from both sour-
ces demonstrate similar resting cell size (17.151.4um vs. 16.554.6um), con-
traction amplitude (4.251.6% vs. 4.452.1%), time to peak contraction
(0.34650.135sec vs. 0.33950.214sec), maximum contraction velocity
(6.3453.50um/sec vs. 7.4654.81um/sec), and maximum relaxation velocity
(3.2152.49um/sec vs. 3.4052.49um/sec).
We have also successfully isolated and purified 20 ug of myosin per million
hESC-CMs. Using flash photolysis to liberate ATP in a solution of actomyosin,
we have shown that the myosin binds actin and is dissociated from the complex
by ATP with the expected 2nd order rate constant (~1 uM1sec1).
In summary, the contractile properties of hESC-CMs and hiPSC-CMs are sim-
ilar to each other but differ from values published for adult human cardiomyo-
cytes, suggesting that they are functionally immature and may benefit from
in vitro maturation efforts.
Support appreciated from NIH HL064387/HL080431, NHLBI T32GMO7266-
35S1, and the Wellcome Trust.
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Cellular cardiomyoplasty to replace non-functional tissue following cardiac in-
farction appears clinically viable. Current strategies utilizing direct injection of
cell suspensions are limited by low cell retention, poor cell localization, and
high cell death. Synthetic biomaterials developed to enhance cell delivery
can lead to problems with immune rejection, degradation, and mechanical mis-
match, preventing functional integration of constructs with host myocardium.
The goal of this project is to develop a functional cardiac tissue construct
with enhanced host integration capabilities as a novel strategy to replace dam-
aged myocardium. We have developed a novel templated fibrin scaffold seeded
with cells to promote functional integration. Fibrin is an ideal scaffold material
because it can be autologous, improves cell attachment and growth, and de-
grades into natural byproducts that can induce angiogenesis. The novel scaffold
architecture includes 1) microchannels spanning the length of the scaffold, al-
lowing alignment and organization of cells to mimic native cardiac tissue struc-
ture, and 2) micropores to enhance construct survival by improving nutrient de-
livery and waste removal. The dense fibrin scaffolds (stiffness ¼ 16.0 5 3.0
kPa) had mechanical properties closer to native myocardium than fibrin gels
(0.5 to < 7 kPa). Centrifuge seeding with a tri-cell mixture of cardiomyocytes,
endothelial cells, and fibroblasts increased scaffold stiffness (38.35 8.9 kPa)
to values near neonatal myocardial tissue (~40 kPa). Stiffness decreased over
time in culture (25.25 3.1 kPa, Day 6), which may indicate ECM formation
and scaffold degradation. Patches of beating cells were observed inside chan-
nels within two days in culture. After three days in culture, histology showed
cardiomyocyte and fibroblast alignment and immature lumen formation. These
results indicate micro-templated fibrin scaffolds are a unique and viable plat-
form for cardiac tissue engineering. This work supported by NIH HL064387
(MR, MS, BR) and NSF GRFP (KT).
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The muscle specific protein NRAP plays a role in myofibril assembly and is up-
regulated in mouse models of dilated cardiomyopathy. We sought to determine
if increased N-RAP expression would directly lead to a cardiomyopathy pheno-
type. Novel transgenic lines were developed using the tet-off system with trans-
genic N-RAP expression requiring the tetracycline transactivator (tTA). tTA
was introduced by mating the N-RAP transgenic animals with well-character-
ized animals carrying the tTA transgene controlled by the cardiac specific al-
pha-myosin heavy chain promoter. Multiple founder lines were examined
and lines showing the most significant increase in NRAP expression were
used for further investigation. N-RAP expression in theses animals was up to
2.5 times greater than control littermates as determined by western blot analy-
sis. Histological examination of hearts from ~12 week old transgenic mice
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amination of these hearts by immunofluorescence microscopy revealed normal
myofibrillar structure and localization of the transgenic protein to intercalated
disks, as normally seen with the endogenous protein. Protein markers for car-
diomyopathy were examined by qPCR and revealed no difference between
non-transgenic and transgenic animals. Echocardiography and magnetic reso-
nance imaging of the N-RAP transgenic animals revealed no significant struc-
tural or functional differences when compared to control littermates at 12
weeks of age. Based on these data, it does not appear that overexpression of
N-RAP directly leads to an observable cardiac phenotype. The alternative hy-
pothesis that upregulation of N-RAP in dilated cardiomyopathy is compensa-
tory remains to explored.
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We sought to establish a model of heart failure (HF) encompassing young and
aged animals to determine if alterations in the amount of cardiac extracellular
matrix (ECM) occur in ageing and whether these changes are similar to those in
HF.
HF was induced in sheep aged 18 months (young) and those over 8 years (old)
by 4 weeks rapid right ventricular pacing (3.5Hz). Paraffin-embedded left ven-
tricular (LV) samples were stained with picro-sirius red. Interstitial collagen
was visualised by polarised light microscopy. LV protein extracts were as-
sessed for MMP activity using gelatin zymography. Statistical significance
was calculated using the mean 5 SEM and a t-test or by 2-way ANOVA.
LV diameter increased with age (OC) compared to young controls (YC)
(3.0450.2cm vs.2.4450.14cm, n=4-13, P<0.05), in young heart failure
(YF) compared pre-pacing (3.8250.1cm vs. 2.4450.1cm, n=13, P<0.001)
and in old heart failure (OF) compared to pre-pacing (3.8750.1cm vs.
3.0450.2cm, n=4, P<0.05). Collagen content increased in OC compared to
YC (2.2750.4% vs. 0.9650.1%, n=5, P<0.05) and in YF compared to YC
(2.6250.3% vs. 0.9650.1%, n=5-8, P<0.001), and decreased in OF compared
to YF (1.2650.4% vs. 2.6250.3%, n=4-8, P<0.01). Normalised MMP-2 ac-
tivity increased in OC (1.5250.08), YF (1.6650.14) and OF (1.7450.17)
compared to YC (0.9850.22, P<0.05, n=6-8).
The commonality of these changes seen in ageing and HF may indicate that car-
diac ECM remodelling is important in the predisposition of ageing to the devel-
opment of HF.
All procedures accord to The UK Animals (Scientific Procedures) Act, 1986.
This work was supported by the British Heart Foundation and EU
‘‘Normacor’’.
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Previously we have characterized the physiological heart hypertrophy which
occurs during pregnancy. However, the underlying molecular mechanisms of
pregnancy-induced hypertrophy are still not elucidated. Here we performed
Western Blot analysis together with high resolution confocal microscopy to
identify the key signaling molecules involved in the pregnancy-induced heart
hypertrophy in non-pregnant in diestrus stage (NP), late pregnant (LP), 24
hours post partum (PP1) and 7 days post partum (PP7) mice. Western Blot anal-
ysis of heart lysates showed that phospho-AKT protein levels were decreased
~ 7 fold at the end of pregnancy (N=4 NP and N=4 LP mice). Interestingly, AKT
activity was restored one day post-partum to levels comparable to NP. There
were no significant changes in total or phosphorylated levels of ERK1/2 with
pregnancy. The calcium/calmodulin-dependent serine-threonine phosphatase
Calcineurin, which has been shown to be upregulated in pathological cardiac
hypertrophy, was significantly downregulated at the end of pregnancy, and
this downregulation was reversed 1 day after partum. The phosphorylation of
the signal transducer and activator of transcription 3 (STAT3), but not its total
protein levels, was also significantly lower at the end of pregnancy and was re-
stored completely one day post-partum. Although there was a tendency in reduc-
tion of phospho-GSK protein levels in the LP group, this reduction was not
statistically significant. High resolution confocal microscopy demonstrated
that pregnancy is associated with relocalization of AKT and pAKT to the nu-
cleus, which is partially reversed 24 hours post-partum. While the subcellulardistribution of ERK1 and pERK was not regulated by pregnancy, the nuclear
labeling of P38, JNK1 and pJNK was significantly upregulated at the end of preg-
nancy. Although pJNK localization disappeared completely from the nucleus in
the PP1 group, P38 and JNK1 nuclear labeling remained high 24 hours PP.
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Recently, several studies have demonstrated G protein coupled receptor 30
(GPER) can directly bind to estrogen and mediate its action. We investigated
the role and the mechanism of estrogen-induced cardioprotection after ische-
mia-reperfusion using a specific GPER agonist G1. Isolated hearts from male
mice were perfused using Langendorff technique with oxygenated (95% O2
and 5% CO2) Krebs Henseleit buffer (control), with addition of G1 (1mM),
and G1 (1mM)þPD98059 (10mM) to investigate the involvement of Erk path-
way. After 20 min of perfusion, hearts were subjected to 20 min global normo-
thermic (37C) ischemia followed by 40min reperfusion. During the course of
experiment cardiac function was measured and myocardial necrosis was eval-
uated by triphenyltetrazolium chloride (TTC) staining at the end of the reper-
fusion. Mitochondria were isolated after 10 minutes of reperfusion to assess the
calcium load required to induce mPTP opening. G1 treated hearts developed
better functional recovery with higher rate pressure product (RPP,
61405264 vs. 26405334 mmHgxbeats/min, p<0.05). The infarct size de-
creased significantly in G1 treated hearts (2152% vs. 4653% p<0.001) and
the Ca2þ load required to induce mPTP opening increased (2.450.06 vs.
1.650.11 mM/mg mitochondrial protein, p<0.05) as compared to the controls.
The addition of PD 98059 significantly prevents G1 effect on heart function
RPP (4120546 mmHgxbeats/min, p<0.05), infarct size (5352%) and calcium
retention capacity (1.450.11mM/mg mitochondrial protein p<0.05) These
results suggest that GPER activation inhibits the mPTP opening and provide
a cardioprotective effect after ischemia-reperfusion and this effect is mediated
by Erk pathway. Supported by NIH and AHA.
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In mitochondria, the main reactive oxygen species (ROS) generators are com-
plexes I and III. Mitochondrial ROS generation has been implicated in cellular
damage occurring in a variety of pathologies including ischemia/reperfusion
(I/R). Most of the studies have observed an increase of ROS production after
I/R. However, there is evidence of an increase of ROS production after cardi-
oprotection by preconditioning interventions.
We investigated the differential production of ROS by complex I and III in I/R
and sham isolated mitochondria heart mice, and the action of pro-apoptotic
drugs (rotenone and antimycin A) on ROS production by these complexes in
sham animals.
Mitochondrial ROS generation by both complexes was measured using amplex
red in the presence of horseradish-peroxidase. Specific substrates for complex I
(glutmate/malate) and complex II (succinate), and the inhibitors (rotenone and
antimycin-A) were used. Mitochondria from I/R mice produced more ROS
than mitochondria from sham when the substrate for complex I was used. In con-
trast, with the substrate of complex II, mitochondria from I/R mice produced less
ROS than sham. Application of rotenone and antimycin-A in mitochondria from
sham heart significantly increased ROS production when the substrate for the
complex I was used. Surprisingly, these inhibitors decreased the ROS production
when the substrate for the complex II was used. This data indicate the ambivalent
production of ROS by the respiratory chain complexes I and III, and suggest op-
posite role of ROS depending on the complex being cardio-deleterious for com-
plex I and cardio-protective for complex III. Supported by NIH and AHA.
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